These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 23057618

  • 1. The role of progesterone in maternal and fetal medicine.
    Di Renzo GC, Giardina I, Clerici G, Mattei A, Alajmi AH, Gerli S.
    Gynecol Endocrinol; 2012 Nov; 28(11):925-32. PubMed ID: 23057618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [Abstract] [Full Text] [Related]

  • 6. Use of progestogens in pregnant and infertile patients.
    Ozlü T, Güngör AC, Dönmez ME, Duran B.
    Arch Gynecol Obstet; 2012 Aug; 286(2):495-503. PubMed ID: 22543698
    [Abstract] [Full Text] [Related]

  • 7. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progesterone in normal and pathological pregnancy.
    Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S.
    Horm Mol Biol Clin Investig; 2016 Jul 01; 27(1):35-48. PubMed ID: 27662646
    [Abstract] [Full Text] [Related]

  • 11. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
    Tempfer CB, Kurz C, Bentz EK, Unfried G, Walch K, Czizek U, Huber JC.
    Fertil Steril; 2006 Jul 01; 86(1):145-8. PubMed ID: 16716321
    [Abstract] [Full Text] [Related]

  • 12. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    Christian MS, Brent RL, Calda P.
    J Matern Fetal Neonatal Med; 2007 Feb 01; 20(2):89-112. PubMed ID: 17437208
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
    Oler E, Eke AC, Hesson A.
    Int J Gynaecol Obstet; 2017 Jul 01; 138(1):12-16. PubMed ID: 28369874
    [Abstract] [Full Text] [Related]

  • 15. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
    Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2005 Sep 01; 193(3 Pt 2):1127-31. PubMed ID: 16157124
    [Abstract] [Full Text] [Related]

  • 16. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM, Prescott GM, Franco A, Fan-Havard P.
    Ann Pharmacother; 2013 Apr 01; 47(4):527-36. PubMed ID: 23535817
    [Abstract] [Full Text] [Related]

  • 17. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G, Schoen C, Franasiak JM, Scott RT, Berghella V.
    Fertil Steril; 2017 Feb 01; 107(2):430-438.e3. PubMed ID: 27887710
    [Abstract] [Full Text] [Related]

  • 18. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC, Mol BW, Bruinse HW.
    Ned Tijdschr Geneeskd; 2010 Feb 01; 154():A1730. PubMed ID: 20858311
    [Abstract] [Full Text] [Related]

  • 19. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, Grifol R, Alcover I, Sala M, Martínez-Escoriza JC, Pellicer A.
    BJOG; 2013 Jan 01; 120(1):50-7. PubMed ID: 22882759
    [Abstract] [Full Text] [Related]

  • 20. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone.
    Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep 01; 38(3):272-80. PubMed ID: 21739497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.